Association of estrogen levels with neuropsychological performance in women with schizophrenia

A. L. Hoff, W. S. Kremen, M. H. Wieneke, J. Lauriello, H. M. Blankfeld, W. O. Faustman, J. G. Csernansky, Thomas E Nordahl

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Objective: This study sought to determine the relationship of estrogen levels with psychiatric symptoms and neuropsychological function in female patients with schizophrenia. Method: Psychiatric symptoms were assessed and average estrogen and progesterone levels from four consecutive weekly blood samples were measured in 22 female inpatients with schizophrenia who were also administered a neuropsychological battery. Results: There were strong positive correlations between average estrogen level and cognitive function, especially measures of global cognitive function, verbal and spatial declarative memory, and perceptual-motor speed. Correlations of hormone levels with psychiatric symptoms were nonsignificant. Conclusions: Higher estrogen levels in female patients with schizophrenia are associated with better cognitive ability. These results may have implications for potential treatment of cognitive dysfunction with adjunctive estrogen in female patients with schizophrenia.

Original languageEnglish (US)
Pages (from-to)1134-1139
Number of pages6
JournalAmerican Journal of Psychiatry
Volume158
Issue number7
DOIs
StatePublished - 2001

Fingerprint

Schizophrenia
Estrogens
Psychiatry
Cognition
Aptitude
Progesterone
Inpatients
Hormones
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Association of estrogen levels with neuropsychological performance in women with schizophrenia. / Hoff, A. L.; Kremen, W. S.; Wieneke, M. H.; Lauriello, J.; Blankfeld, H. M.; Faustman, W. O.; Csernansky, J. G.; Nordahl, Thomas E.

In: American Journal of Psychiatry, Vol. 158, No. 7, 2001, p. 1134-1139.

Research output: Contribution to journalArticle

Hoff, AL, Kremen, WS, Wieneke, MH, Lauriello, J, Blankfeld, HM, Faustman, WO, Csernansky, JG & Nordahl, TE 2001, 'Association of estrogen levels with neuropsychological performance in women with schizophrenia', American Journal of Psychiatry, vol. 158, no. 7, pp. 1134-1139. https://doi.org/10.1176/appi.ajp.158.7.1134
Hoff, A. L. ; Kremen, W. S. ; Wieneke, M. H. ; Lauriello, J. ; Blankfeld, H. M. ; Faustman, W. O. ; Csernansky, J. G. ; Nordahl, Thomas E. / Association of estrogen levels with neuropsychological performance in women with schizophrenia. In: American Journal of Psychiatry. 2001 ; Vol. 158, No. 7. pp. 1134-1139.
@article{3c082e1166494783b31dca1d0acc4f19,
title = "Association of estrogen levels with neuropsychological performance in women with schizophrenia",
abstract = "Objective: This study sought to determine the relationship of estrogen levels with psychiatric symptoms and neuropsychological function in female patients with schizophrenia. Method: Psychiatric symptoms were assessed and average estrogen and progesterone levels from four consecutive weekly blood samples were measured in 22 female inpatients with schizophrenia who were also administered a neuropsychological battery. Results: There were strong positive correlations between average estrogen level and cognitive function, especially measures of global cognitive function, verbal and spatial declarative memory, and perceptual-motor speed. Correlations of hormone levels with psychiatric symptoms were nonsignificant. Conclusions: Higher estrogen levels in female patients with schizophrenia are associated with better cognitive ability. These results may have implications for potential treatment of cognitive dysfunction with adjunctive estrogen in female patients with schizophrenia.",
author = "Hoff, {A. L.} and Kremen, {W. S.} and Wieneke, {M. H.} and J. Lauriello and Blankfeld, {H. M.} and Faustman, {W. O.} and Csernansky, {J. G.} and Nordahl, {Thomas E}",
year = "2001",
doi = "10.1176/appi.ajp.158.7.1134",
language = "English (US)",
volume = "158",
pages = "1134--1139",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "7",

}

TY - JOUR

T1 - Association of estrogen levels with neuropsychological performance in women with schizophrenia

AU - Hoff, A. L.

AU - Kremen, W. S.

AU - Wieneke, M. H.

AU - Lauriello, J.

AU - Blankfeld, H. M.

AU - Faustman, W. O.

AU - Csernansky, J. G.

AU - Nordahl, Thomas E

PY - 2001

Y1 - 2001

N2 - Objective: This study sought to determine the relationship of estrogen levels with psychiatric symptoms and neuropsychological function in female patients with schizophrenia. Method: Psychiatric symptoms were assessed and average estrogen and progesterone levels from four consecutive weekly blood samples were measured in 22 female inpatients with schizophrenia who were also administered a neuropsychological battery. Results: There were strong positive correlations between average estrogen level and cognitive function, especially measures of global cognitive function, verbal and spatial declarative memory, and perceptual-motor speed. Correlations of hormone levels with psychiatric symptoms were nonsignificant. Conclusions: Higher estrogen levels in female patients with schizophrenia are associated with better cognitive ability. These results may have implications for potential treatment of cognitive dysfunction with adjunctive estrogen in female patients with schizophrenia.

AB - Objective: This study sought to determine the relationship of estrogen levels with psychiatric symptoms and neuropsychological function in female patients with schizophrenia. Method: Psychiatric symptoms were assessed and average estrogen and progesterone levels from four consecutive weekly blood samples were measured in 22 female inpatients with schizophrenia who were also administered a neuropsychological battery. Results: There were strong positive correlations between average estrogen level and cognitive function, especially measures of global cognitive function, verbal and spatial declarative memory, and perceptual-motor speed. Correlations of hormone levels with psychiatric symptoms were nonsignificant. Conclusions: Higher estrogen levels in female patients with schizophrenia are associated with better cognitive ability. These results may have implications for potential treatment of cognitive dysfunction with adjunctive estrogen in female patients with schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=0034936585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034936585&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.158.7.1134

DO - 10.1176/appi.ajp.158.7.1134

M3 - Article

VL - 158

SP - 1134

EP - 1139

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 7

ER -